Loading
JPXHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
¥2,049
−¥22.00 · -1.06%
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Latest quote
¥2,049
−¥22.00 · -1.06%
Regular session · JST · Market data may be delayed.
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Day range
Current ¥2,049
52-week range
Current ¥2,049
Regular session · JST · Market data may be delayed.
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Day range
Current ¥2,049
52-week range
Current ¥2,049
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 71.13B JPY | 64.14B JPY | 62.84B JPY | 60.46B JPY | 56.61B JPY |
| Cost of goods sold | 36.98B JPY | 32.8B JPY | 32.18B JPY | 31.88B JPY | 30.26B JPY |
| Gross profit | 34.15B JPY | 31.34B JPY | 30.67B JPY | 28.59B JPY | 26.35B JPY |
| Research and development | 7.06B JPY | 7.03B JPY | 4.73B JPY | 4.23B JPY | 3.6B JPY |
| Selling, general, and administrative | 21.25B JPY | 18.97B JPY | 19.44B JPY | 19.25B JPY | 17.96B JPY |
| Operating expenses | 28.31B JPY | 26B JPY | 24.16B JPY | 23.48B JPY | 21.56B JPY |
| Interest income | — | 6M JPY | 4M JPY | — | — |
| Interest expense | 222M JPY | 51M JPY | 40M JPY | 50M JPY | 56M JPY |
| Depreciation and amortization | 3.09B JPY | 2.25B JPY | 2.66B JPY | 3.13B JPY | 2.89B JPY |
| Operating income | 5.83B JPY | 5.33B JPY | 6.5B JPY | 5.11B JPY | 4.8B JPY |
| Net income | 5.43B JPY | 5.1B JPY | 7.55B JPY | 4.24B JPY | 4.29B JPY |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥57.00
2025 complete year+307.1% since 2021
2026 partial: ¥33.00
¥14.00
2,021
¥16.00
2,022
¥28.00
2,023
¥45.00
2,024
¥57.00
2,025
¥33.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥32.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥33.00Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥33.00Semi-Annual | Mar 31, 2026 | Jun 25, 2026 |
Dividend | Sep 29, 2025 | ¥27.00Semi-Annual | Sep 30, 2025 | Nov 28, 2025 |
Dividend | Mar 28, 2025 | ¥30.00Semi-Annual | Mar 31, 2025 | Jun 25, 2025 |
Dividend | Sep 27, 2024 | ¥25.00Semi-Annual | Sep 30, 2024 | Nov 29, 2024 |
Ex-dividend Sep 29, 2026
¥32.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥33.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥33.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 25, 2026
Ex-dividend Sep 29, 2025
¥27.00
Semi-Annual
Record Sep 30, 2025 · Payment Nov 28, 2025
Ex-dividend Mar 28, 2025
¥30.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 25, 2025
Ex-dividend Sep 27, 2024
¥25.00
Semi-Annual
Record Sep 30, 2024 · Payment Nov 29, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T102.76M0.00%2.9T JPY0.05%¥421.6+0.12%
Vanguard Total International Stock ETFVXUS3.7M0.00%646.2B USD0.05%$88.41+0.50%
Vanguard FTSE Developed Markets ETFVEA2.82M0.00%315B USD0.03%$73.76+0.44%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS1.02M0.01%13.6B USD0.06%$161.34+0.42%
Avantis International Small Cap Value ETFAVDV858.11K—20.38B USD0.36%$113.75+0.07%
Schwab International Small-Cap Equity ETFSCHC565.59K0.01%5.68B USD0.06%$51.62+0.27%
Dimensional - International Small Cap Value ETFDISV533.02K0.01%5.24B USD0.42%$44.98+0.04%
Dimensional - International Small Cap ETFDFIS417.09K0.01%5.86B USD0.39%$37.67+0.13%iShares Core TOPIX ETF1475.TVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAVanguard FTSE All-World ex-US Small-Cap ETFVSSAvantis International Small Cap Value ETFAVDVSchwab International Small-Cap Equity ETFSCHCDimensional - International Small Cap Value ETFDISVDimensional - International Small Cap ETFDFISAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
